Term ends Sep 25, 2029 · Low confidence
20-year base term ends Dec 28, 2026
Grace period ended Nov 11, 2026 · no payment on record as of the Nov 17, 2026 fee file · lapse expected
Held by Pharmacyclics LLC
Filed Jun 8, 2010 as application 12/594,805 · Granted Nov 11, 2014
Base term plus 1002 days of patent term adjustment (USPTO delay)
Today
2006
2029
Clock starts
Dec 28, 2006
Dec 28, 2006
Term ends
Sep 25, 2029
Sep 25, 2029
Granted
Nov 11, 2014
Nov 11, 2014
base term
patent term adjustment
fee events
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
1,002
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
76
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term runs 1002 days past its 20-year base term on prosecution delay. 2 of 3 maintenance fees are paid so far. Confidence: Low: the grace period for its third maintenance fee ended Nov 11, 2026 with no payment on record. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Dec 28, 2006, when application 11/617,645, the earliest non-provisional in its chain, was filed (this one was filed Jun 8, 2010) | Dec 28, 2026 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +1002 days, USPTO patent term adjustment record | Sep 25, 2029 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | Read from the payments on the fee record: none for this window, and its grace period has ended. No fee event states a lapse, and USPTO's status still reads "Patented Case". | grace period ended Nov 11, 2026 | Low confidence |
| Computed term end | The steps above, in order | Sep 25, 2029 | Low confidence |
Partial family
| US 7,514,444 | In force no later than Dec 2026 | no later than Dec 2026 |
| US 7,732,454 | In force Apr 2027 | Apr 2027 |
| US 7,825,118 | In force Jan 2028 | Jan 2028 |
| Application PCT/US2008/058528 | PCT application no patent term | no patent term |
| US 8,088,781 | In force no later than Dec 2027 | no later than Dec 2027 |
| US 8,501,751 | In force Dec 2026 | Dec 2026 |
| US 8,008,309 | In force Nov 2027 | Nov 2027 |
| Application 12/499,008 | Abandoned not computed | not computed |
8 of 76 applications in this family shown, earliest filings first. Partial: 6 of the 76 have no file history here, so a row comes from the patent's own record or names the application alone. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jul 13, 2010 Reel 24676, frame 157 | Honigberg, Lee; Verner, Erik J.; Buggy, Joseph J.; Loury, David J.; Chen, Wei | Pharmacyclics, Inc. | Assignment of Assignor's Interest |
| Jul 16, 2015 Reel 36126, frame 377 | Oxford Amherst Corporation | Pharmacyclics, Inc. | Merger |
| Jul 16, 2015 Reel 36126, frame 398 | Pharmacyclics, Inc.; Oxford Amherst LLC | Pharmacyclics LLC | Merger and Change of Name |
| May 17, 2016 Reel 38722, frame 776 | Oxford Amherst Corporation; Pharmacyclics, Inc. | Pharmacyclics, Inc. | Corrective Assignment to Correct the Conveying Party Data Previously Recorded on Reel 036126 Frame 0377. Assignor(S) Hereby Confirms the Merger. |
| May 17, 2016 Reel 38722, frame 849 | Pharmacyclics, Inc.; Oxford Amherst LLC | Pharmacyclics LLC | Corrective Assignment to Correct the Conveying Party Data Previously Recorded on Reel 036126 Frame 0398. Assignor(S) Hereby Confirms the Merger and Change of Name. |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Nov 11
Grace period ended Nov 11, 2026 with no payment on record. The term ends early once USPTO posts the lapse
Sep 2029
Term ends Sep 25, 2029.
Note
The 1002 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
258
later US patents cite this one
That is top 5% of utility patents granted in 2014 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.